Vitamin D3 for Aromatase Inhibitor Induced Arthralgias

Summary

The primary purpose is to determine if high dose vitamin D3 reduces the incidence of musculoskeletal symptoms associated with the aromatase inhibitor letrozole in women with early stage breast cancer and low serum vitamin D levels.

Timeline

Start

2009-03

Primary completion

2011-01

Completion

2011-01

Drugs

Indications